HIV and AIDS Trial, Recruiting NCT06741618 Sponsor: Columbia University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06741618
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 16 to 25 years old
  • People who identify as male or non-binary
  • People who were assigned male sex at birth
  • People who can read and understand English
  • People who own a smartphone
  • People who have had anal sex without a condom with a male partner in the past year
  • People who have tested HIV-negative, confirmed using an OraQuick test

Who may not be able to join:

  • People who are HIV-positive
  • People where trial staff determine that the person is unable to give informed consent due to obvious and severe cognitive impairment, or because they are under the influence of drugs or alcohol at the time of enrolment
  • People who are already consistently using PrEP (a medication taken to prevent HIV)
  • People who are currently taking part in another HIV prevention research study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert Garofalo, MD, MPH, Ann & Robert H Lurie Children's Hospital of Chicago

Phone: 212-342-6886

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
30 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PrEP Initiation:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov